Global Information
회사소개 | 문의 | 위시리스트

면역 레퍼토리 시퀀싱 시장 : 제품 종류별, 용도별, 최종사용자별, 지역별 - 세계 산업 인사이트, 동향, 전망, 기회 분석

Immune Repertoire Sequencing Market, by Product Type (Instruments, and Reagents and Kits), by Application, by End User, and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 -2025

리서치사 Coherent Market Insights
발행일 2019년 02월 상품 코드 798068
페이지 정보 영문
가격
US $ 4,500 ₩ 5,379,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,367,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 11,954,000 PPT Turned PDF (Enterprise User License)


면역 레퍼토리 시퀀싱 시장 : 제품 종류별, 용도별, 최종사용자별, 지역별 - 세계 산업 인사이트, 동향, 전망, 기회 분석 Immune Repertoire Sequencing Market, by Product Type (Instruments, and Reagents and Kits), by Application, by End User, and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 -2025
발행일 : 2019년 02월 페이지 정보 : 영문

세계의 면역 레퍼토리 시퀀싱(Immune Repertoire Sequencing) 시장에 대해 분석했으며, 기술 개요와 시장의 기본 구조, 성장 촉진·억제요인, 전체적인 시장 규모 전망, 제품 종류별·용도별·최종사용자별·지역별 상세 동향, 주요 기업 개요, 업계 관계자가 향후 해결해야 할 과제 등을 조사했습니다.

제1장 분석 목적과 가정

제2장 시장 개요

  • 분석 개요
  • 주요 요약
  • COM(Coherent Opportunity Map : 시장 기회 맵)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
    • 시장 기회
  • 영향도 분석
  • 시장 동향
  • 주요 발전
  • 규제 상황
  • 제품 리콜
  • 역학적 분석
  • 기술 개요
  • PEST 분석
  • Porter's Five Forces 분석

제4장 면역 레퍼토리 시퀀싱 시장 : 제품 종류별

  • 서론
    • 시장 점유율 분석(최신·예측)
    • 시장 성장률 분석(통산 10년간)
    • 부문별 분석
  • 어세이 키트
    • 서론
    • 시장 규모, 연간 성장률과 예측(금액 기준, 향후 9년간)
    • T세포 수용체(TCR) 키트
    • B세포 수용체(BCR) 키트
  • 측정장치

제5장 면역 레퍼토리 시퀀싱 시장 : 용도별

  • 서론
  • 암면역요법
  • 바이오마커 탐색
  • 자가면역질환
  • 백신 개발과 효능
  • 이식 거부반응과 내성
  • 감염증
  • 기타 용도

제6장 면역 레퍼토리 시퀀싱 시장 : 최종사용자별

  • 서론
  • 임상 검사실
  • 바이오테크놀러지 및 제약 기업
  • 교육 및 연구 기관
  • 기타

제7장 면역 레퍼토리 시퀀싱 시장 : 지역별

  • 서론
  • 북미(미국, 캐나다)
    • 시장 규모와 예측 : 제품 종류별(금액 기준, 향후 9년간)
    • 시장 규모와 예측 : 용도별(금액 기준, 향후 9년간)
    • 시장 규모와 예측 : 최종사용자별(금액 기준, 향후 9년간)
    • 시장 규모와 예측 : 국가별(금액 기준, 향후 9년간)
  • 유럽(영국, 독일, 이탈리아, 프랑스, 스페인, 러시아 등)
  • 아시아태평양(중국, 일본, 인도, ASEAN 국가, 호주, 한국 등)
  • 라틴아메리카(브라질, 멕시코, 아르헨티나 등)
  • 아프리카(북부/중부/남부 아프리카)
  • 중동(걸프협력회의(GCC) 국가, 이스라엘 등)

제8장 경쟁 상황

  • 기업 개요
    • Thermo Fisher Scientific, Inc.
      • 기업 개요
      • 제품 프로파일
      • 재무 실적
      • 최근 주요 동향
      • 전략
    • Illumina Inc.
    • ArcherDX, Inc.
    • Roche Holding AG
    • Pacific Biosciences
    • CD Genomics
    • Atreca, Inc.
    • Adaptive Biotechnologies
    • Oxford Nanopore Technologies, Ltd.
    • Qiagen N.V.
    • Agilent Technologies, Inc.
    • Takara Bio Inc.
  • 애널리스트의 견해

제9장 부록

KSM 19.03.20

Immune repertoire refers to sub-type protein that an organism's immune system creates. Immune systems in vertebrates have six key types of proteins- two immunoglobulin and four T cell receptors. Immune repertoire sequencing enables researchers and scientists to examine and understand adaptive immune-mediated diseases. Immune repertoire sequencing is also widely applicable in biomarker discovery, infectious disease research, asthma and allergy research, and cancer immunotherapy.

Market Dynamics

Increasing prevalence of cancer worldwide is expected to boost immune repertoire sequencing market growth. According to National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. Moreover, the number of people suffering from cancer is expected to reach to 19 million by 2024. According to the Cancer Atlas, 2012, about 1.1 million new cancer cases and 600,000 cancer deaths are reported annually in Latin America and the Caribbean, where lung cancer is the leading cause of cancer death for both sexes.

However, factors such as high cost associated with certain sequencing platforms and data analytic services coupled with product recalls are expected to hinder growth of the immune repertoire sequencing market during the forecast period. For instance, in 2015, Illumina Inc. recalled its Illumina MiSeqDx Universal Kit 1.0, due to software limitation when using the product on MiSeqDx instrument. The software could not report insertions or deletions at specific genomic locations with respect to the primer.

Key features of the study:

  • This report provides in-depth analysis of the immune repertoire sequencing market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global immune repertoire sequencing market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Thermo Fisher Scientific, Inc., Illumina Inc., ArcherDX, Inc., Roche Holding AG, Pacific Biosciences, CD Genomics, Atreca, Inc., Adaptive Biotechnologies, Oxford Nanopore Technologies, Ltd., Qiagen N.V., Agilent Technologies, Inc., and Takara Bio, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global immune repertoire sequencing market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for immune repertoire sequencing market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation

  • Global Immune Repertoire Sequencing Market, By Product Type:
    • Assay Kits
      • T-Cell Receptor (TCR) Kits
      • B-Cell Receptor (BCR) Kits
    • Instruments
  • Global Immune Repertoire Sequencing Market, By Application:
    • Cancer Immunotherapy
    • Biomarker Discovery
    • Autoimmune Diseases
    • Vaccine Development and Efficacy
    • Transplant Rejection and Tolerance
    • Infectious Diseases
    • Other Applications
  • Global Immune Repertoire Sequencing Market, By End User:
    • Diagnostic Labs
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutes
    • Others
  • Global Immune Repertoire Sequencing Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Product Type:
    • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
    • Instruments
      • By Application:
    • Cancer Immunotherapy
    • Biomarker Discovery
    • Autoimmune Diseases
    • Vaccine Development and Efficacy
    • Transplant Rejection and Tolerance
    • Infectious Diseases
    • Other Applications
      • By End User:
    • Diagnostic Labs
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutes
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Product Type:
    • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
    • Instruments
      • By Application:
    • Cancer Immunotherapy
    • Biomarker Discovery
    • Autoimmune Diseases
    • Vaccine Development and Efficacy
    • Transplant Rejection and Tolerance
    • Infectious Diseases
    • Other Applications
      • By End User:
    • Diagnostic Labs
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutes
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Product Type:
    • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
    • Instruments
      • By Application:
    • Cancer Immunotherapy
    • Biomarker Discovery
    • Autoimmune Diseases
    • Vaccine Development and Efficacy
    • Transplant Rejection and Tolerance
    • Infectious Diseases
    • Other Applications
      • By End User:
    • Diagnostic Labs
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutes
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Product Type:
    • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
    • Instruments
      • By Application:
    • Cancer Immunotherapy
    • Biomarker Discovery
    • Autoimmune Diseases
    • Vaccine Development and Efficacy
    • Transplant Rejection and Tolerance
    • Infectious Diseases
    • Other Applications
      • By End User:
    • Diagnostic Labs
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutes
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
      • By Product Type:
    • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
    • Instruments
      • By Application:
    • Cancer Immunotherapy
    • Biomarker Discovery
    • Autoimmune Diseases
    • Vaccine Development and Efficacy
    • Transplant Rejection and Tolerance
    • Infectious Diseases
    • Other Applications
      • By End User:
    • Diagnostic Labs
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutes
    • Africa
      • By Country:
    • South Africa
    • Central Africa
    • North Africa
      • By Product Type:
    • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
    • Instruments
      • By Application:
    • Cancer Immunotherapy
    • Biomarker Discovery
    • Autoimmune Diseases
    • Vaccine Development and Efficacy
    • Transplant Rejection and Tolerance
    • Infectious Diseases
    • Other Applications
      • By End User:
    • Diagnostic Labs
    • Biotechnology and Pharmaceutical Companies
    • Academic and Research Institutes
  • Company Profiles
    • Thermo Fisher Scientific, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Illumina Inc.
    • ArcherDX, Inc
    • Roche Holding AG
    • Pacific Biosciences
    • CD Genomics
    • Atreca, Inc.
    • Adaptive Biotechnologies
    • Oxford Nanopore Technologies, Ltd.
    • Qiagen N.V.
    • Agilent Technologies, Inc.
    • Takara Bio, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Landscape
  • Product Recall
  • Epidemiology Analysis
  • Technology Overview
  • PEST Analysis
  • Porter's Five Forces model

4. Global Immune Repertoire Sequencing Market, By Product Type, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Assay Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
    • T-Cell Receptor (TCR) Kits
    • B-Cell Receptor (BCR) Kits
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)

5. Global Immune Repertoire Sequencing Market, By Application, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Cancer Immunotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Biomarker Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Autoimmune Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Vaccine Development and Efficacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Transplant Rejection and Tolerance
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)

6. Global Immune Repertoire Sequencing Market, By End User, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Diagnostic Labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Biotechnology and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)

7. Global Immune Repertoire Sequencing Market, By Region, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

8. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Illumina Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • ArcherDX, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Roche Holding AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Pacific Biosciences
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • CD Genomics
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Atreca, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Adaptive Biotechnologies
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Oxford Nanopore Technologies, Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Qiagen N.V.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Agilent Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Takara Bio, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top
전화 문의
F A Q